Alefacept - a drug review.
Alefacept is an immunobiologic agent that has been recently introduced in the treatment of plaque psoriasis. The author presents a brief review of the drug, its efficacy and safety profile. Recent case reports of the use of alefacept in conjunction with other conditions as well as the drug's possible use for treatment of other conditions are reviewed as well.
Lev-Tov
Hadar
H
Department of Dermatology, Mount Sinai School of Medicine, 5 East 98th, Street, Box 1048, 5th Floor, New York, NY 10029-6574, USA.
Hadi
Suhail
S
D000077944:Alefacept; D002986:Clinical Trials as Topic; D003879:Dermatologic Agents / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D006801:Humans; D011565:Psoriasis / Q000188:drug therapy*; D011993:Recombinant Fusion Proteins / Q000627:therapeutic use*; D016896:Treatment Outcome
D003879:Dermatologic Agents; D011993:Recombinant Fusion Proteins; D000077944:Alefacept